List of Elestrin drug patents

Elestrin is owned by Mylan Speciality Lp.

Elestrin contains Estradiol.

Elestrin has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Elestrin are:

  • US7198801

Elestrin was authorised for market use on 15 December, 2006.

Elestrin is available in gel, metered;transdermal dosage forms.

The generics of Elestrin are possible to be released after 25 June, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7198801 MYLAN SPECIALITY LP Formulations for transdermal or transmucosal application
Jun, 2022

(7 months ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 15 December, 2006

Treatment: NA

Dosage: GEL, METERED;TRANSDERMAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in